SCHEMBL6090836

SCHEMBL6090836

O=C(Nc1c(C(=O)O)n(Cc2ccc(Cl)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.47
ABCB1 P08183 1/20 0.45
PTGER4 P35408 1/20 0.44
PTGES2 Q9H7Z7 3/20 0.43
PTGES O14684 1/20 0.43
SERPINE1 P05121 1/20 0.43
EGLN2 Q96KS0 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
EGLN3 Q9H6Z9 1/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CCR9 P51686 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6089976 0.93 PTGES (0.44) PPARGABCB1PTGER4PTGES2PTGES
SCHEMBL6091451 0.86 SLC2A1 (0.44) PPARGABCB1PTGER4PTGESEGLN2
SCHEMBL6091652 0.80 SERPINE1 (0.54) PPARGPTGES2PTGESSERPINE1CCR9
SCHEMBL6091368 0.78 GRIN1 (0.43) PPARGPTGER4PTGESEGLN2EGLN1
SCHEMBL6091492 0.78 THRB (0.43) PPARGPTGES2PTGESSERPINE1MAPT
SCHEMBL6090166 0.78 EDNRA (0.47) PPARGABCB1MAPTMEN1TSHR
SCHEMBL6093040 0.77 SERPINE1 (0.45) PPARGABCB1PTGES2PTGESSERPINE1
SCHEMBL4701667 0.76 PTGES (0.46) PPARGPTGESMAPTMEN1KMT2A
SCHEMBL6090163 0.76 ABCB1 (0.41) ABCB1PTGER4EGLN2EGLN1EGLN3
SCHEMBL5749488 0.76 PTGER4 (0.46) PPARGABCB1PTGER4PTGESSERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 PPARG 481/4885ABCB1 1475/4885PTGER4 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.